Baseline HbA1c, %*	n (%)	<5.7	5.7–<6.5	6.5–<8.0	≥8.0	Missing
HbA1c, %
<5.7	36 (29.3)	15 (41.7)	14 (38.9)	7 (19.4)	0	0
5.7–<6.5	68 (55.3)	6 (8.8)	28 (41.2)	29 (42.6)	4 (5.9)	1 (5.6)
6.5–<8.0	18 (14.6)	0	1 (5.6)	8 (44.4)	8 (44.4)	1 (5.6)
Missing	1 (0.8)†	0	0	0	1 (100)	0

Includes data from the core and extension phase. Classification of patients as diabetic, pre-diabetic, or non-diabetic was performed according to multiple criteria as stated in the Methods.

^*Baseline is defined as the last available value on or before the study drug start date;

^†One patient had missing mGH and IGF-I values at baseline.